Our key to success is a flexible
and cost-effective business model
The Enorama Pharma business model is to develop and manufacture consumer friendly medicated chewing gums using our ChewMed® technology which is a unique compressed gum technology. We operate in a business-to-business context leaving the Enorama Pharma organization lean and agile. Key activities such as R&D, clinical studies, regulatory affairs are outsourced to global partners. Sales and marketing are out licensed to our customers.